Max Healthcare Approves PRSU Scheme 2026 and Strategic MOA Alterations
Max Healthcare Institute Ltd · Others (Uncategorized) · 20 Oct 2026, 3:27 am
Max Healthcare Approves PRSU Scheme 2026 and Strategic MOA Alterations Max Healthcare Institute shareholders approved the Performance Linked Restricted Stock Unit (PRSU) Scheme 2026 via postal ballot on 19th Oct'26. The scheme covers up to 73.50 lakh equity shares (~0.76% of paid-up capital as of 13th Aug'26) for eligible employees of the company and subsidiaries at an exercise price equal to face value (₹10/share). Additionally, members approved altering the Memorandum of Association's Main Objects Clause to expand into medical education/colleges, pharmaceuticals and radiopharmaceuticals manufacturing via particle accelerator facilities, and in-house food and beverage services.
Original exchange filing (PDF)
More announcements from Max Healthcare Institute Ltd
- Presentation for Investor Conference · 14 Nov 2026
- Transcript of Earnings Call held on November 3, 2026 · 10 Nov 2026
- Schedule of Investor Conference · 05 Nov 2026
- Audio Recording of Earnings Call held on November 3, 2026 · 04 Nov 2026
- Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 · 04 Nov 2026
- Change in Senior Management Personnel · 30 Oct 2026
- Presentation of earnings update for the quarter and half year ended September 30, 2026 · 30 Oct 2026
- Press Release - Max Healthcare Q2 revenue rises to Rs. 3,219 Cr, registering growth of 20% YoY; Q2 PAT stood at Rs. 448 Cr, growth of 10% YoY · 30 Oct 2026
